These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36669759)

  • 1. The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation.
    Zeng J; Shu Q; Lu C; Wang Y
    ESC Heart Fail; 2023 Apr; 10(2):1454-1460. PubMed ID: 36669759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends and procedural safety of transcatheter mitral valve repair with mitraclip in patients with hypertrophic cardiomyopathy: Insights from the national inpatient sample.
    Faisaluddin M; Balasubramanian S; Ahmed A; Hussain K; Nso N; Gaznabi S; Erwin JP; Pursnani A; Ricciardi M
    Curr Probl Cardiol; 2024 Mar; 49(3):102354. PubMed ID: 38135106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Edge to Edge Mitral Valve Repair for Mitral Regurgitation in Hypertrophic Cardiomyopathy: A Case Series.
    Carasso S; Marmor DB; Shuvy M
    Can J Cardiol; 2024 Feb; 40(2):326-328. PubMed ID: 38042340
    [No Abstract]   [Full Text] [Related]  

  • 4. Transcatheter edge-to-edge mitral valve repair in patients with acute decompensated heart failure due to severe mitral regurgitation.
    Makmal N; Silbermintz N; Faierstein K; Raphael R; Moeller C; Canetti M; Maor E; Kuperstein R; Hai I; Butnaru A; Oren D; Barbash IM; Guetta V; Fefer P
    Cardiol J; 2024; 31(1):45-52. PubMed ID: 37345364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year results following PASCAL-based or MitraClip-based mitral valve transcatheter edge-to-edge repair.
    Geis NA; Schlegel P; Heckmann MB; Katus HA; Frey N; Crespo López P; Raake PWJ
    ESC Heart Fail; 2022 Apr; 9(2):853-865. PubMed ID: 35170230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    Sorajja P; Pedersen WA; Bae R; Lesser JR; Jay D; Lin D; Harris K; Maron BJ
    J Am Coll Cardiol; 2016 Jun; 67(24):2811-8. PubMed ID: 27311518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation?
    Wan CK; Dearani JA; Sundt TM; Ommen SR; Schaff HV
    Ann Thorac Surg; 2009 Sep; 88(3):727-31; discussion 731-2. PubMed ID: 19699887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of MitraClip to Target Obstructive SAM in Severe Diffuse-Type Hypertrophic Cardiomyopathy: Case Report and Review of Literature.
    Long A; Mahoney P
    J Invasive Cardiol; 2020 Sep; 32(9):E228-E232. PubMed ID: 32865508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral valve repair or replacement in hypertrophic obstructive cardiomyopathy: a prospective randomized study.
    Bogachev-Prokophiev A; Afanasyev A; Zheleznev S; Fomenko M; Sharifulin R; Kretov E; Karaskov A
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):356-362. PubMed ID: 28575282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter edge-to-edge repair for secondary mitral regurgitation with third-generation devices in heart failure patients - results from the Global EXPAND Post-Market study.
    Orban M; Rottbauer W; Williams M; Mahoney P; von Bardeleben RS; Price MJ; Grasso C; Lurz P; Zamorano JL; Asch FM; Maisano F; Kar S; Hausleiter J
    Eur J Heart Fail; 2023 Mar; 25(3):411-421. PubMed ID: 36597850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-obstructive hypertrophic cardiomyopathy with mitral regurgitation requiring valve replacement.
    Nawa S; Yamamoto T; Tsuji K; Nakata T; Miyachi Y; Hayashi K
    Cardiovasc Surg; 1993 Jun; 1(3):305-7. PubMed ID: 8076051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
    Ailawadi G; Lim DS; Mack MJ; Trento A; Kar S; Grayburn PA; Glower DD; Wang A; Foster E; Qasim A; Weissman NJ; Ellis J; Crosson L; Fan F; Kron IL; Pearson PJ; Feldman T;
    Circulation; 2019 Jan; 139(1):37-47. PubMed ID: 30586701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair: 1-Year Results From the EXPAND Study.
    Kar S; von Bardeleben RS; Rottbauer W; Mahoney P; Price MJ; Grasso C; Williams M; Lurz P; Ahmed M; Hausleiter J; Chehab B; Zamorano JL; Asch FM; Maisano F
    JACC Cardiovasc Interv; 2023 Mar; 16(5):589-602. PubMed ID: 36922046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afterload mismatch after transcatheter mitral valve repair with MitraClip for degenerative mitral regurgitation in acute cardiogenic shock.
    Tang GHL; Cohen M; Dutta T; Undemir C
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E168-E171. PubMed ID: 28303686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of rehospitalization after percutaneous edge-to-edge mitral valve repair by MitraClip implantation.
    Keßler M; Seeger J; Muche R; Wöhrle J; Rottbauer W; Markovic S
    Eur J Heart Fail; 2019 Feb; 21(2):182-192. PubMed ID: 30178493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral valve interventions in heart failure.
    Lavall D; Hagendorff A; Schirmer SH; Böhm M; Borger MA; Laufs U
    ESC Heart Fail; 2018 Aug; 5(4):552-561. PubMed ID: 29676043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Treatment of Functional Mitral Regurgitation in Patients with Heart Failure: The COAPT Trial.
    Sodhi N; Lim DS
    Interv Cardiol Clin; 2020 Oct; 9(4):451-459. PubMed ID: 32921369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of the transcatheter mitral valve repair for patients with severe mitral regurgitation and endangered heart failure.
    Lee CW; Huang WM; Tsai YL; Lu DY; Sung SH; Yu WC; Guo CY; Chen CH
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):452-459. PubMed ID: 32620461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.